Gaurang J. Gandhi, PharmD, MHA, CSP, SPCB President, is an industry consultant, previously with Accredo Healthcare Group. He has more than 15 years of specialty pharmacy experience in variety of settings. He has written commentaries and spoken on specialty pharmacy topics such as REMS. He is a graduate of College of Pharmacy, University of Arkansas and has health care administration degree from the SUNY. He has further served various pharmacy organizations such as AMCP and regional pharmacy societies in Delaware, Florida, and New York.
George Zula, RPh, MBA, CSP, SPCB Vice President, is Vice President of Operational Programs and Solutions at US Bioservices, an AmerisourceBergen Specialty Group Company. In this role, George is responsible for payer and manufacturer implementations, contracting, data analytics, clinical initiatives, compliance, training, accreditations and partner reporting. George has over 20 years of experience in specialty pharmacy; spanning a broad range of functions within the industry including operations, managed care strategy, business development and payer relations. He has worked for several leading specialty pharmacies including CVSProCare (formerly Statlander Drug Company), Accredo, Coram Healthcare and Prime Therapeutics. George is a registered pharmacist, earning his Pharmacy degree from the University of Pittsburgh and his MBA from Waynesburg University.
Gary Rice, RPh, MS, MBA, CSP SPCB Immediate Past President, is the Vice President of Clinical Services at Diplomat Specialty Pharmacy, where he provides leadership, strategy, and planning for all clinical functions across Diplomat Specialty Pharmacy. He works closely with Operations, IT, Business Development, Sales and Marketing, and Managed Markets for tactical positioning and clinical service support from development through implementation, and over sees clinical initiatives and services. Gary has over 30 years of pharmacy experience in PBM, managed markets, home infusion, DME, retail, and hospital pharmacy. Gary earned his Bachelor of Science in Pharmacy from the Massachusetts College of Pharmacy and Allied Health Sciences in Boston.He received a Masters of Science in Pharmacy from the University of Houston, and completed a Pharmacy Residency Program accredited by the American Society of Health-System Pharmacists at the Veterans Administration Medical Center in Houston. Gary completed his Masters in Business Administration from the University of Phoenix.
Ray Tancredi, RPh, MBA, CSP, SPCB Past President, Vice President, Specialty Pharmacy Development at Walgreens, oversees a team responsible for all specialty pharmacy trade functions including: Specialty Pharmacy product access and relationships, managing manufacturer hub services and referrals, contract negotiation, implementation and compliance, pharma programs and services, data analysis and reporting, RFP support and coordinating clinical, patient services, new drug in-services and education. Additionally, Ray oversees management of strategic manufacturer accounts in an effort of maximize contracts and provide exceptional customer service.
Ray joined Walgreens Specialty Pharmacy in December 2008 as Director, Trade Account Management. Prior to his work with Walgreens, Ray joined McKesson in 2000 to manage implementation of specialty pharmacy programs for managed care organizations. He was promoted to Director, Clinical Marketing and given responsibilities that included development of clinical programs and strategies for targeted therapeutic categories. Ray also had responsibilities for the McKesson Specialty Health Network, a network of chain retail pharmacies where McKesson supports specialty pharmacy capabilities.
Dr. Donald Filibeck, PharmD, MBA,CSP, FASHP, Secretary/Treasurer serves as Critical Care Systems’ National Director, Pharmacy Services, providing operational and clinical pharmacy support for all CCS branch locations. He received his Bachelor of Science in Pharmacy and Doctorate of Pharmacy degrees from the University of Michigan and his Master of Business Administration degree from Baldwin-Wallace College, Berea, Ohio.During his 25 plus years in the home infusion industry, he has held a number of different roles, ranging from branch pharmacy manager to regional infusion manager for a large, national infusion company to national director, pharmacy services for a large specialty injection/infusion provider. He has been responsible for running the day-to-day operations (including reimbursement) for a hospital-based infusion program and has overseen clinical services in a large, multi-site regional provider. Responsibilities have also included sales support, clinical protocol development, staff training, site evaluation and Joint Commission preparation.
Steve Kennedy, PharmD, CSP, is Manager of Quality and Accreditation for Walgreens Local Specialty pharmacies. His responsibilities include Quality Improvement, Compliance, and Accreditation for 275+ pharmacies. Steve also collaborates on specialty strategy, training, patient safety, and patient management initiatives. He has spent over 25 years in home infusion where he held increasing responsible positions, including National Director of Pharmacy Services for Walgreens Infusion Services, before moving into specialty pharmacy. Steve received his Doctor of Pharmacy degree from the University of Illinois at Chicago in 1989.
Sandra Matsumoto , RPh, CSP, is the Director of Specialty Pharmacy Practice for CVS Caremark, with responsibility for development, implementation and management of corporate programs which define and regulate the practice of pharmacy for CVS Caremark Specialty pharmacies. Sandra’s primary areas of responsibilities of include oversight of pharmacy operations processes and procedures, legal & regulatory compliance, and accreditation programs.She works cross-functionally to support many aspects of the CVS Caremark Specialty Pharmacy business, including the areas of clinical programs, training & continuing education, trade relations, performance improvement, and logistics. Sandra began her pharmacy career as a hospital pharmacist, specializing in neonatal care, before moving into the field of home infusion and Specialty pharmacy, where she has held various positions for the past 28 years. Sandra earned her Bachelor of Science in Pharmacy from the University of Illinois College of Pharmacy in Chicago.
Kelly Mathews, PharmD, CSP is the Director, Clinical Services at Avella Specialty Pharmacy since 2012. Kelly earned her Doctor of Pharmacy degree from the University of Arizona, College of Pharmacy in 2009. Her post-graduate education has included a community residency with The Apothecary Shops in Phoenix, Arizona. In her current role, she is responsible for developing clinical content for counseling and mid-therapy wellness check on patients taking specialty medications from home, including administration/dosing, ADE/adherence management and measuring efficacy and outcomes. Through this, Kelly has contributed to multiple research projects and publications. She is also the Residency Director for Avella Specialty Pharmacy’s PGY1 Community Pharmacy residency and is adjunct faculty with Midwestern College of Pharmacy, Glendale campus.
Brandon Newman, PharmD, CSP, MMHC is a graduate of the University of Tennessee, holding Bachelor of Science and Doctor of Pharmacy degrees. Brandon received his Master of Management in Health Care from the Owen Graduate School of Business at Vanderbilt University. With more than 12 years of Specialty Pharmacy experience, across adult and pediatric enterprises, Brandon has served in various roles at Accredo, Medco, Express Scripts and Vanderbilt Specialty Pharmacies. In 2012 he piloted the “Embedded Specialty Clinical Pharmacist” model that Vanderbilt uses in its clinics today. As the Program Director of Specialty Pharmacy Services, Brandon is the market access liaison and works closely with manufactures and payers to ensure that Vanderbilt patients have access to high cost self-administered medications.
Physician Board Director
William B. Bunn, MD, JD, MPH, recently retired as the Vice President of Health, Safety, Security and Productivity and now serves as Consultant/Advisor to Navistar International Corporation, originally International Harvester. Dr. Bunn came to International as Medical Director in 1995, assumed additional responsibilities as Director of Health Management and Safety in January 1997, Vice President of Health, Safety and Productivity in 1999 and Vice President of Health, Safety, Security and Productivity in 2003. He has been a professor and taught Environmental Health Sciences since 1997 at Northwestern University Medical School.Prior to joining Navistar, Dr. Bunn served as Assistant Professor and Director of Research for Occupational and Environmental Medicine and Internal Medicine at Duke University Medical Center; Senior Director for Occupational Health and Environmental Affairs for the Pharmaceutical Research and Development Division of Bristol Myers; Corporate Medical Director and Senior Director of Health, Safety and Environment for the Johns Manville Corporation; and International Medical Director of Mobil Corporation.
Dr. Bunn is a fellow and former board member and officer of the American College of Occupational and Environmental Medicine. He holds membership in the Society of Toxicology, International Society of Travel Medicine, American Industrial Hygiene Association, International Commission on Occupational Health and Society of Occupational Medicine. Dr. Bunn has chaired and served on committees of the National Academies (NA), EPA, NIOSH and OSHA including the EPA Scientist Advisory Board, NIOSH Board of Scientific Counselors and National Advisory Committee on Occupational Safety and Health.
Public Board Director
Dr. Balch has a decade of executive leadership in the non-profit sector with an emphasis on consensus-building and collaboration. From 2006 – 2013, he served as the Vice President of the Preventive Health Partnership — a national health promotion collaboration between the American Cancer Society, American Diabetes Association, and American Heart Association. Prior to his work with the Preventive Health Partnership, Dr. Balch was the Executive Director of Friends of Cancer Research.
He has led numerous federal advocacy efforts on a range of issues both at the legislative and regulatory level over the years. For example, he helped to organize and lead a coalition that successfully fought for improvements in the regulatory process for the review of cancer drugs at the Food and Drug Administration (FDA). He also contributed to the development of key federal policies related to the Affordable Care Act.
Dr. Balch serves on the Executive Board of the Patient Advocate Foundation and National Patient Advocate Foundation. Dr. Balch also is a member of the National Committee for Quality Assurance’s Wellness and Health Promotion Advisory Committee, a member of the Guiding Committee for the Health Care Payment Learning and Action Network (LAN). and serves on the Advisory Board for the Patient Resource Cancer Guides, the Partnership to Fight Chronic Disease, and the External Advisory Board for the Hutchinson Institute for Cancer Outcomes Research (HICOR). Dr. Balch also serves on the Finance Committee for the National Health Council in Washington, DC. and recently accepted an invitation to join the inaugural board for The American Journal of Managed Care’s (AJMC) newest initiative, the Institute for Value-Based Medicine (IVBM).
He earned his PhD in environmental studies in 2003 from the University of California, Santa Cruz; his master’s degree in environmental sciences in 1997 from the University of Texas in San Antonio; his bachelor’s degree (cum laude) in biology in 1994 from Trinity University in San Antonio.
Corporate Board Director
Terrie Livingston, PharmD – As the Senior Director, U.S. Medical, Head of Innovation and External Partnerships at Biogen, Terrie Livingston is responsible for developing and building medical excellence and engagement with key External Partners (Providers, Payers, Advocacy Groups, Professional Societies and Healthcare Policy Makers) in the U.S. to develop medical leadership across Biogen’ s therapeutic areas. Additionally, she is responsible for developing innovative strategic collaborations focused on improving patient outcomes and being a partner to support in the healthcare transformation through best in class HCP education, external partnerships to advance research and understanding of our disease areas of focus and supporting regulatory pathways and access to treatment, implementation of novel quality improvement initiatives, and ensuring Biogen partnerships to optimize our impact on improving healthcare and providing value based solutions. Terrie also has held senior roles in U.S. Medical within Biogen. Terrie has over 18 years of Managed Care expertise and 15 years of Pharmaceutical/Life Sciences experience. She is also an entrepreneur being a Managing/Equity Partner and Vice President of Pharmacy Operations and Business Development for a Specialty Pharmacy in California. She earned a Pharm.D. from University of California, San Francisco (UCSF), before completing both a general residency and a specialty residency in Home Infusion and Business Administration.
Kathy D Webster, PharmD, PhD, was named the KGI School of Pharmacy’s founding dean and will help guide it through the accreditation process. Dr. Webster has extensive experience helping to establish and working with new schools of pharmacy, including the University of Maryland Eastern Shore School of Pharmacy, where she recently served as professor and associate dean of academic affairs. Previously, she was the assistant dean and chair of pharmaceutical sciences and a professor at Feik School of Pharmacy, University of Incarnate Word in San Antonio, Texas. She held several positions at Campbell University in Buies Creek, North Carolina, including director of science education outreach, director of the pharmaceutical analysis laboratory and associate and assistant professor of medicinal chemistry. Also, as head of the analytical section there, she helped found and develop the Campbell University Pharmaceutical Sciences Institute (CUPSI), which provided contract services to small local and regional pharmaceutical companies. She holds a Doctor of Pharmacy from the University of the Pacific in Stockton, California, and a PhD in medicinal chemistry from the University of Minnesota, Minneapolis.
Kathy Puglise, MSN/ED, BSN, RN, CRNI®, has been a registered nurse for 26 years. She has clinical experience in emergency room, critical care, and infusion nursing. Kathy has her Master of Science in Nursing with a specialization in health care education. In addition she is board certified in infusion nursing which is credentialed by the Infusion Nurses Certification Corporation and accredited by the American Board of Nursing Specialities (ABNS).
Kathy has served on the Infusion Nurses Board of Directors as the President from 2012-2103, and currently is the presidential advisor. In addition, Kathy was on the Infusion Nursing Certifications RN council as an expert in question development and evaluation of the CRNI (certified registered nurse infusion) from 2003-2011.
Currently Kathy is the Vice President of Infusion Nursing for BioScrip, Inc. She leads the team of over 450 nurses in the provision of safe-quality effective administration of infusion therapy. Kathy focuses her team on data research to provide evidence of positive patient outcomes measures.